Distonía tardía

Lerner PP, Miodownik C, Lerner V. Tardive dyskinesia (syndrome) : Current concept and modern approaches to its management. Psychiatry and clinical neurosciences 2015; 69(6): 321-34.

Bhidayasiri R, Boonyawairoj S. Spectrum of tardive syndromes: clinical recognition and management. Postgraduate medical journal 2011; 87(1024): 132-41.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC; 2013.

Bhidayasiri R, Fahn S, Weiner WJ, et al. Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013; 81(5): 463-9.

Orti-Pareja M, Jimenez-Jimenez FJ, Vazquez A, et al. Drug-induced tardive syndromes. Parkinsonism & related disorders 1999; 5(1-2): 59-65.

Keegan DL, Rajput AH. Drug induced dystonia tarda: treatment with L-dopa. Diseases of the nervous system 1973; 34(3): 167-9.

Krack P, Schneider S, Deuschl G. Geste device in tardive dystonia with retrocollis and opisthotonic posturing. Movement disorders: official journal of the Movement Disorder Society 1998; 13(1): 155-7.

Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982; 32(12): 1335-46.

Adityanjee, Aderibigbe YA, Jampala VC, Mathews T. The current status of tardive dystonia. Biological psychiatry 1999; 45(6): 715-30.

Sethi KD. Drug-Induced Movement Disorders. 1 ed: CRC Press; 2004.

Ryu S, Yoo JH, Kim JH, et al. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study. Journal of clinical psychopharmacology 2015; 35(1): 13-21.

Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain: a journal of neurology 1998; 121 ( Pt 11): 2053-66.

Casey DE. Tardive dyskinesia: pathophysiology and animal models. The Journal of clinical psychiatry 2000; 61 Suppl 4: 5-9.

Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor and other hyperkinetic movements 2013; 3.

Corson PW, Nopoulos P, Miller DD, Arndt S, Andreasen NC. Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. The American journal of psychiatry 1999; 156(8): 1200-4.

Skidmore F, Reich SG. Tardive Dystonia. Current treatment options in neurology 2005; 7(3): 231-6.

Vijayakumar D, Jankovic J. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs 2016; 76(7): 779-87.

Pinninti NR, Faden J, Adityanjee A. Are Second-Generation Antipsychotics Useful in Tardive Dystonia? Clinical neuropharmacology 2015; 38(5): 183-97.

Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Movement disorders: official journal of the Movement Disorder Society 1986; 1(3): 193-208.

Sobstyl M, Zabek M. Deep brain stimulation for intractable tar-dive dystonia: Literature overview. Neurologia i neurochirurgia polska 2016; 50(2): 114-22.